Search clinical trials for: Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)

Total 11 results

Biotyx Medical (Shenzhen) Co., Ltd.
VascuScience GmbH; Mediolanum Cardio Research Srl; Euroimage Research Srl

Recruiting

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Critical Limb Ischemia | Infrapopliteal Lesions

Italy
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease (GENIUS)

Critical Limb Ischemia (CLI)

China
Biotyx Medical (Shenzhen) Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery Stenosis (IRIS)

Pulmonary Artery Stenosis

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Active, not recruiting

A First-in-Man Study of IBS (IBS-FIM)

Single Coronary Vessel Disease

China
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

Single Coronary Vessel Disease

Malaysia
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-III)

Coronary Artery Disease

China
Biotyx Medical (Shenzhen) Co., Ltd.

Active, not recruiting

A Clinical Investigation to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease (IRONMAN-II)

Coronary Artery Disease

China
Meril Life Sciences Pvt. Ltd.

Unknown

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System (MeRes-1Extend)

Coronary Artery Disease

Malaysia, Brazil, Indonesia, Macedonia, The Former Yugoslav Republic of
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease. (MeReS100-China)

Coronary Artery Disease
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan

3

Subscribe